J Exp Clin Cancer Res 2008, 27:15.PubMedCrossRef 12. Liao CF, Luo SF, Shen TY, Lin CH,
Chien JT, Du SY, Jiang MC: CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep 2008, 41:210–216.PubMed 13. Liao CF, Luo SF, Tsai CS, Tsao TY, Chen SL, Jiang MC: CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: use of CAS for high-sensitivity anticancer drug screening. Toxicol Mech Methods 2008, 18:771–776.PubMedCrossRef 14. Bursch W, Karwan A, Mayer M, Dornetshuber J, Fröhwein www.selleckchem.com/products/gsk1120212-jtp-74057.html U, Schulte-Hermann R, Fazi B, Di Sano F, Piredda L, Piacentini M, Petrovski G, Fésüs L, Gerner C: Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology 2008, KU-57788 concentration 254:147–157.PubMedCrossRef 15. Brinkmann U, Brinkmann E, Gallo M, Scherf U, Pastan I: Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry 1996, 35:6891–6899.PubMedCrossRef 16. Bera TK, Bera J, Brinkmann U, Tessarollo L, Pastan I: Cse1l is essential for early embryonic growth and development. Mol Cell Biol 2001, 21:7020–7024.PubMedCrossRef
17. Shajahan AN, Wang A, Decker M, Minshall RD, Liu MC, Clarke R: Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity. J Biol Chem 2007, 282:5934–5943.PubMedCrossRef 18. Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L: Microtubule associated protein (MAP)-tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle 2005, 4:1149–1152.PubMedCrossRef 19. Yvon AM, Wadsworth P, Jordan MA: Taxol suppresses dynamics of individual microtubules in living human tumor cells.
Mol Biol Cell 1999, 10:947–959.PubMed 20. Banerjee S, Fallis AG, Brown DL: Differential effects of taxol on two human cancer cell lines. Oncol Res 1997, 9:237–248.PubMed 21. Kumar S: The apoptotic cysteine protease CPP32. Int J Biochem Cell Biol 1997, 29:393–396.PubMedCrossRef 22. Peiró G, Diebold J, Baretton GB, Kimmig R, Löhrs U: Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol 2001, Cediranib (AZD2171) 20:359–367.PubMedCrossRef 23. Jiang MC, Lin TL, Lee TL, Huang HT, Lin CL, Liao CF: IRF-1-mediated CAS expression enhances interferon-gamma-induced apoptosis of HT-29 colon adenocarcinoma cells. Mol Cell Biol Res Commun 2001, 4:353–358.PubMedCrossRef 24. Haupt S, Berger M, Goldberg Z, Haupt Y: Apoptosis-the p53 network. J Cell Sci 2003, 116:4077–4085.PubMedCrossRef 25. Wang S, El-Deiry WS: The p53 pathway: targets for the development of novel cancer therapeutics. Cancer Treat Res 2004, 119:175–187.PubMedCrossRef 26. Ling X, Calinski D, Chanan-Khan AA, Zhou M, Li F: Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.